Recruiting NCT06613880
Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia
Aplastic Anemia · TPO Receptor Agonists
Hematology
3,640 trials in this section
Recruiting NCT04533217
Examination of Vertebroplasty in Addition to Regular Treatment of Patients With Multiple Myeloma.
Vertebral Fracture · Multiple Myeloma
Recruiting NCT06534463
Registry Study of Chinese Patients with Marginal Zone Lymphoma (MOTIVE)
Marginal Zone Lymphoma
Recruiting NCT05904106
Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML
Acute Myeloid Leukemia
Not yet recruiting NCT06712173
Linperlisib Combined With EZH2 Inhibitor in Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL)
Peripheral T Cell Lymphoma
Not yet recruiting NCT06712030
Effect of Angiotensin Receptor/Neprilysin Inhibitors on Transthyretin Cardiac Amyloidosis and Heart Failure with Reduced Ejection Fraction
Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
Recruiting NCT06245629
Bortezomib-bendamustine-melphalan vs Melphalan for Multiple Myeloma
Myeloma Multiple
Recruiting NCT06704555
Radiotherapy Followed by Tiselizumab Combined With RCHOP in Previously Untreated Bulky Follicular Lymphoma
Follicular Lymphoma
Recruiting NCT06612944
Prophylactic Intervention for Relapse Prevention Post-Allogeneic Transplantation in Very High-Risk MDS Patients Based on IPSS-M Stratification
Myelodysplastic Syndromes, Adult
Recruiting NCT06697483
Risk Stratification and MRD-driven Maintenance for MM After ASCT
Multiple Myeloma
Not yet recruiting NCT06702605
To Evaluate XNW5004 Tablets in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma
Relapsed/Refractory Peripheral T Cell Lymphoma
Recruiting NCT06702566
The Effect of Serum Ferritin in irAE
Immune-related Adverse Event · Malignant Solid Tumors · Acute Leukemia
Recruiting NCT06476171
Validation of Hematological Indices
Multiple Organ Dysfunction · Sepsis · Pneumonia
Not yet recruiting NCT06701344
Go-CHOP in de Novo Intestinal T-cell Lymphoma Patients
Enteropathy Associated T Cell Lymphoma
Not yet recruiting NCT06702098
Induced Pluripotent Stem Cells Derived Natural Killer Cells Therapy for Refractory and Relaps Acute Myelogenous Leukemia
Acute Myeloid Leukemia (AML)
Recruiting NCT06588413
Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan
Multiple Myeloma · Autologous Stem Cell Transplantation
Recruiting NCT04741945
Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS
Preleukemia · Myelodysplastic Neoplasm · Cytopenia
Recruiting NCT05333367
MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy
Cutaneous T-Cell Lymphoma · Graft Vs Host Disease · Graft Rejection
Recruiting NCT04834024
MIL62 Combined With Lenalidomide Versus Lenalidomide for Patients With Rituximab Refractory Follicular Lymphoma
Follicular Lymphoma and Marginal Zone Lymphoma
Not yet recruiting NCT06697990
Cerebrospinal Fluid Immune Microenvironment Mechanism in Anaplastic Lymphoma Kinase Positive Lung Cancer Patients
Carcinoma, Non-Small-Cell Lung
Recruiting NCT04110301
MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL)
Follicular Lymphoma and Marginal Zone Lymphoma
Recruiting NCT06566586
A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma
B-cell Lymphoma
Recruiting NCT06696833
Allogeneic CD19-targeted CAR-γδT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
B-Cell Acute Lymphoblastic Leukemia, Adult
Recruiting NCT05806099
A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy Study of MBS303 in B-Cell NHL
Non-Hodgkin's Lymphoma
Recruiting NCT06693973
An Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
B-cell Non-Hodgkin Lymphoma (B-NHL)
Recruiting NCT06393985
Decitabine, Venetoclax and Blinatumomab for Maintenance Following HSCT in Patients With Ph-Negative B-ALL
B-cell Acute Lymphoblastic Leukemia
Not yet recruiting NCT06656221
A Prospective, Single-Center Study Evaluating the Efficacy and Safety of Glofitamab Combined With Orelabrutinib and Bortezomib in Patients With High-Risk Mantle Cell Lymphoma
Mantle Cell Lymphoma
Recruiting NCT06695741
Reduced Dose of Cyclophosphamide Combined With Standard Immunosuppressive Therapy to Treat Severe Aplastic Anemia
Severe Aplastic Anemia · Cyclophosphamide Reduced-dose · Immunosuppressive Therapy
Recruiting NCT06693791
Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT
Platelet Recovery After Umbilical Cord Blood Transplantation
Recruiting NCT06674096
RLC Followed by CR-CHOP in Elderly Patients with Newly-diagnosed DEL
Double-expressor Lymphoma
Recruiting NCT05924100
Efficacy and Safety of Luspatercept for the Treatment of Anemia Due to MDS With del5q, Refractory/Resistant/Intolerant to Prior Treatments, RBC-TD
Myelodysplastic Syndromes · Del(5Q) · Anemia
Recruiting NCT05910801
Tafasitamab, Lenalidomide and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
Recurrent Mantle Cell Lymphoma · Refractory Mantle Cell Lymphoma
Recruiting NCT06034275
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
Acute Myeloid Leukemia · B-cell Acute Lymphoblastic Leukemia · High-risk Myelodysplastic Syndrome
Recruiting NCT06539169
FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
Alpha-Thalassemia · Beta-Thalassemia · Amyloidosis
Recruiting NCT06643962
Venetoclax Combined with Intensive Therapy for Acute Myeloid Leukemia Patients with Lower Early Peripheral Blast Clearance Rate After Standard Induction Therapy
Leukemia · Leukemia, Myeloid · Leukemia, Myeloid, Acute
Not yet recruiting NCT06684509
Atorvaststin and Cardiotoxicity in Acute Myloid Leukemia
Leukemia · Hodgkin Disease
Recruiting NCT06682156
Conversion to Carfilzomib Therapy in Bortezomib Intolerant Newly Diagnosed Multiple Myeloma(NDMM) Patients
Newly Diagnosed Multiple Myeloma
Recruiting NCT06683885
A Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophosphamide, and Prednisone for the Primary Treatment of Elderly Patients with Newly Diagnosed Diffuse Large B-cell Lymphoma
Newly Diagnosed Diffuse Large B-cell Lymphoma
Recruiting NCT05156203
Safety and Tolerability Study for T-1301 Capsules to Treat Advanced Solid Tumors
Advanced Solid Tumor · Lymphoma
Recruiting NCT04168502
Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML
Acute Myeloid Leukemia
Recruiting NCT06644118
A Study of OL-101 Injection in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
Multiple Myeloma
Recruiting NCT06678282
JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia
B-NHL · B-ALL
Recruiting NCT05196789
Diagnosis and Phenotype Characterisation Using Genomics in Patients With Inherited Bone Marrow Failure (IBMDx Study)
Inherited BMF Syndrome · Inherited Platelet Disorder · Hematologic Diseases
Recruiting NCT06073860
A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia
Myelodysplastic Syndrome · Beta Thalassemia
Recruiting NCT06073769
A Post-Marketing Surveillance Study to Assess the Safety of Oral Azacitidine Maintenance Therapy in Korean Patients With Acute Myeloid Leukemia
Acute Myeloid Leukemia
Not yet recruiting NCT06671717
Pralatrexate Combined With Chidamide Bridging Allogeneic HSCT for Refractory/Relapsed Peripheral T-cell Lymphoma
Relapsed Peripheral T-Cell Lymphoma · Refractory Peripheral T-Cell Lymphoma
Recruiting NCT06395870
Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
B-Cell Non-Hodgkin Lymphoma-Recurrent · B-Cell Non-Hodgkin Lymphoma-Refractory
Not yet recruiting NCT06674330
Using a Population Pharmacokinetic Model to Estimate the Dosage of Teicoplanin in Patients With Hematologic Malignancy or Critical Illness
Hematological Malignancies · Critical Illness
Recruiting NCT05703126
Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML
Acute Myeloid Leukemia, Adult · Cardiotoxicity · Endothelial Dysfunction
Not yet recruiting NCT06674850
Systemic Inflammation Response Index and C-Reactive Protein to Albumin Ratio in Acute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia
Not yet recruiting NCT06673459
BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients
T-Cell Lymphocytic Leukemia · ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION · Total Body Irradiation
Not yet recruiting NCT06672263
A Clinical Trial to Evaluate the Safety and Tolerability of TQB3911 Tablets in Patients With BCR::ABL Fusion Gene Positive Leukemia
Chronic Myelogenous Leukemia
Recruiting NCT05503134
Safety and Efficacy of Expanded, Universal Donor Natural Killer Cells for Relapsed/Refractory AML
Acute Myeloid Leukemia
Not yet recruiting NCT06667583
5p15/ 9q22/ 15q22 Hyperdiploidy and Their Significance in Multiple Myeloma Patients
Multiple Myeloma, Neoplasms
Enrolling by invitation NCT06583395
Quest to Analyze One Thousand Humans Meditating
Amyotrophic Lateral Sclerosis (ALS) · Angina, Stable · Anxiety
Not yet recruiting NCT06668948
The Prognostic Role of Fibrinogen to Albumin Ratio in Acute Leukemia Patients
Patients with Acute Leukemia
Recruiting NCT06235216
Sacituzumab govitEcan in THYroid Cancers
Differentiated Thyroid Cancer · Anaplastic Thyroid Cancer
Not yet recruiting NCT06669143
Zanubrutinib-based Maintenance Therapy of Newly Diagnosed DLBCL With Initial Remission
Diffuse Large B Cell Lymphoma
Recruiting NCT06665412
Efficacy and Safety of Dose Redution of Radotinib as a First Line Treament in Ph+ CML
Chronic Phase Ph+ Chronic Myeloid Leukemia
Enrolling by invitation NCT06664541
Decision-Making and Quality of Life Surrounding Hematologic Disease and Gene Therapy
Transfusion Dependent Beta Thalassemia · Sickle Cell Disease
Recruiting NCT06176027
Azacytidine Plus CAOLD Regimen in Relapsed/Refractory Peripheral T-Cell Lymphomas
Relapsed Peripheral T-Cell Lymphomas · Refractory Peripheral T-Cell Lymphomas
Not yet recruiting NCT06660459
Pattern of Menorrhagic Female Attending the Hematology Unit in Assuit University Children Hospital
Menorrhagia
Recruiting NCT03459534
A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs
Chronic Myeloid Leukemia, Chronic Phase · CML, Chronic Phase · CML, Refractory
Recruiting NCT06659653
Safety and Efficacy of PRG-2302 for Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia Disease.
Acute Lymphoblastic Leukemia
Not yet recruiting NCT06658938
Blinatumomab as Maintenance Therapy in Patients With High-risk B-lineage Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation
B-ALL
Recruiting NCT05662540
PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma
NK/T-cell Lymphoma
Recruiting NCT06659276
Comparison Between Whole Body DWI and FDG PET/CT in Patients with Simptomatic Multiple Myeloma
Multiple Myeloma
Not yet recruiting NCT06658925
Olverembatinib as Maintenance Therapy or Preemptive Therapy After Allo-HSCT in Ph+ALL
Ph+ Acute Lymphoblastic Leukemia (Ph+ALL) · HSCT · Tyrosine Kinase Inhibitor
Not yet recruiting NCT06656234
The Effectiveness and Safety of Glofitamab in Real-World Clinical Practice Among Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter Study
Diffuse Large B Cell Lymphoma (DLBCL)
Not yet recruiting NCT06655519
An Exploratory Study of RD140 Injection in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
Relapsed/Refractory Multiple Myeloma · Plasma Cell Leukemia
Recruiting NCT05806580
Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma
Relapsed or Refractory B-cell Lymphoma
Recruiting NCT05348213
Novel Targeted Drugs Combined With R-ICE Regimen in Relapsed and Refractory Diffuse Large B-cell Lymphoma
Diffuse Large B Cell Lymphoma
Recruiting NCT04587856
Molecular Mechanisms of Disease Relapse After Allogenic Stem Cell Transplantation in MDS Patients
Myelodysplastic Syndromes
Recruiting NCT06647940
Orelabrutinib in Combination with R-CHOP for CD5-positive DLBCL Patients（Rocket Trial）
Diffuse Large B Cell Lymphoma (DLBCL)
Recruiting NCT05726110
Selinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid Leukemia
Relapsed or Refractory Acute Myeloid Leukemia
Not yet recruiting NCT06652139
Selinexor Combined With BEAM for ASCT in R/R DLBCL With MYC Positive
Diffuse Large B Cell Lymphoma
Not yet recruiting NCT06652685
Molecular Subtype Combined with Early Minimal Residual Disease to Optimize the Treatment of Newly Diagnosed Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML)
Not yet recruiting NCT06652152
Mechanism Investigation of R-CHOP Regimen or Tucidinostat Plus R-CHOP (CR-CHOP) Regimen in the Treatment of BCL2/MYC Protein Double Expressor Lymphoma
Diffuse Large B Cell Lymphoma (DLBCL) · Double Expressor Lymphoma
Not yet recruiting NCT06651203
Evaluation of the KIR3DL2 Marker in Flow Cytometry for Sézary Syndrome Diagnosis, Therapeutic Response and Residual Disease: a Prospective and Multicenter Study
Mycosis Fungoides/Sezary Syndrome · Cutaneous T Cell Lymphoma
Recruiting NCT05961410
Eltrombopag for Peripheral Blood Stem Cell Harvest
Lymphoma · Peripheral Blood Stem Cell Transplantation
Recruiting NCT05546723
LMY-920 for Treatment of Relapsed or Refractory Myeloma
Multiple Myeloma, Refractory · Multiple Myeloma in Relapse
Not yet recruiting NCT06649422
Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter Study
Leukemia, Lymphocytic, Acute, Adult
Recruiting NCT06183489
Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma
Smoldering Multiple Myeloma
Recruiting NCT04859218
Revisiting the Universal Donor: Does Exposure to O Blood Products Affect Patient Outcomes?
Myelodysplastic Syndrome
Not yet recruiting NCT06646211
High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ)
Primary Central Nervous System Lymphoma (PCNSL) · Non Hodgkin Lymphoma (NHL)
Enrolling by invitation NCT06646978
Long-term Risk of Second Primary Malignancies for Chronic Myeloid Leukaemia in the French Imatinib-based SPIRIT Trial
Chronic Myeloid Leukemia (CML)
Recruiting NCT02586389
Specimen Collection from Patients with Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay
Non-hematologic Cancer
Recruiting NCT06458374
ATTR Cardiac Amyloidosis in a Selected Population
ATTR Amyloidosis Wild Type · ATTR Gene Mutation · Carpal Tunnel Syndrome
Recruiting NCT06625372
Comparison of Intralipid With SMOF Lipid Following HSCT
Leukemia · HSCT
Recruiting NCT05299424
A Study of CM336 in Patients With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Recruiting NCT05931718
Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia
Autoimmune Hemolytic Anemia · Immune Thrombocytopenia · Chronic Idiopathic Neutropenia
Not yet recruiting NCT06549335
Zanubrutinib, Obinutuzumab and Lenalidomide (ZGR) in High-risk Treatment-naive Patients with Follicular Lymphoma (FL)
Follicular Lymphoma
Recruiting NCT04070040
Camrelizumab for Patients with Recurrent Primary Central Nervous System Lymphoma (PCNSL)
Primary Central Nervous System Lymphoma
Recruiting NCT04275518
A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS.
Acute Myeloid Leukemia (AML) · Myelodysplastic Syndromes (MDS)
Recruiting NCT06636552
An Investigator-Initiated, Phase II, Multicenter, Open-Label, Single-Arm, Prospective Clinical Trial to Evaluate the Efficacy and Safety of Alternating Bortezomib-Based Regimens in Combination With DaratUMumab Followed by Maintenance With Daratumumab in the Frontline Setting of Primary Plasma CEll L
Primary Plasma Cell Leukemia
Not yet recruiting NCT06631196
Jacobson's Progressive Muscle Relaxation Technique on Children With Leukemia Undergoing Chemotherapy.
Leukemia · Children · Fatigue Related to Cancer Treatment
Recruiting NCT06626893
Integrative "Omics" Approaches for Leukemia Target Identification and Matched Therapeutic Intervention
Myeloid Leukemia, Acute · Leukemia, Acute Lymphoblastic
Recruiting NCT06625203
A Non-interventional, International, Multicentre Clinical Research Study to Build the Largest Collection of Multimodal Data (Including Clinical Data, Imaging Data and Omics Data) in Oncology
Diffuse Large B Cell Lymphoma · Solid Tumor Cancer
Recruiting NCT06284395
Two Schemes Response in Multiple Myeloma
Response, Acute Phase · Survivorship
Recruiting NCT06471946
VA Conditioning Regimen Allo-HSCT for Elderly Higher-risk MDS
Higher-risk Myelodysplastic Syndromes